Overview

Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes

Status:
Completed
Trial end date:
2002-03-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of the trial is to investigate the effect of NNC 90-1170 (liraglutide) on weight and appetite in obese subjects with type 2 diabetes treated with diet and/or sulphonylurea or repaglinide.
Phase:
Phase 2
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Liraglutide